Studies suggest it can accelerate the healing of muscles, tendons, and ligaments, making it popular among athletes and individuals recovering from injuries
She suffers from severe mental retardation, multifocal epilepsy, hyperkinetic movement disorder, astigmatism, hyperopia, strabismus, and QTc elongation
Share this article with them and let me know what they think
Discover Our Peptide Portfolio In 2023, the FDA reviewed several peptides nominated for compounding and placed many on the 503A Category 2 list.[3] Then in 2024, the agency cited limited clinical safety data, along with concerns about immunogenicity (how the immune system might respond) and dosing variability.[4] It was a precautionary decision, and precaution is an important part of regulatory oversight
TB-500: 2mg injected subcutaneously (anywhere, like the abdomen), twice per week (e.g., Monday and Thursday)
Limitations: Animal models only